In vitro activity of tigecycline against multidrug-resistant Enterobacteriaceae isolates from skin and soft tissue infections

BACKGROUND: Tigecycline, a new agent against multidrug-resistant (MDR) bacteria, is especially licensed for use in complicated skin and soft tissue and intra-abdominal infections. We aimed to study the recent in vitro activity of tigecycline against MDR Enterobacteriaceae skin and soft tissue isolat...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohanty, Srujana, Mahapatra, Ashoka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Experimental Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840812/
https://www.ncbi.nlm.nih.gov/pubmed/33537135
http://dx.doi.org/10.1016/j.amsu.2021.01.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840812/
https://www.ncbi.nlm.nih.gov/pubmed/33537135
http://dx.doi.org/10.1016/j.amsu.2021.01.010

Ejemplares similares